Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract

E-ISSN： 1873-4286|9|27|2253-2266

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.27, 2003-10, pp. : 2253-2266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preface [Hot topic: Implications of COX-2 Inhibition in the Gastrointestinal Tract (Executive Editor : Angel Lanas)]

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : i-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot topic: Implications of COX-2 Inhibition in the Gastrointestinal Tract (Executive Editor : Angel Lanas)]

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : ii-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of Cancer in the Upper Gastrointestinal Tract with COX-Inhibition. Still an Option?

Current Pharmaceutical Design, Vol. 13, Iss. 22, 2007-08 ,pp. : 2261-2273

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular and Renovascular Implications of COX-2 Inhibition

Current Pharmaceutical Design, Vol. 10, Iss. 6, 2004-02 ,pp. : 603-611

Bentham Science Publishers

Access to resources Recommend Favorite

COX-2 Inhibition, H. pylori Infection and the Risk of Gastrointestinal Complications

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2213-2219

Bentham Science Publishers

Access to resources Recommend Favorite